logo
Select company
Select metric
$ 1.07MInterest Expense
VS
Market
57
Sector
40
Industry
27
History
-
$ 12.53Close
$ 10.25 - $ 49 52-Week Range
Ticker Information

Ticker

CBIO

Company Name

CRESCENT BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CRESCENT BIOPHARMA INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CBIO - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 1.07M
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CRESCENT BIOPHARMA INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 0.
  • Over the past 5 years, CRESCENT BIOPHARMA INC's average Int. Exp. has been $ 53.65K.
  • The median Int. Exp. for CRESCENT BIOPHARMA INC during this period was $ 0
  • CRESCENT BIOPHARMA INC reached its highest Int. Exp. over the past 5 years at $ 1.07M.
  • The lowest Int. Exp. recorded by CRESCENT BIOPHARMA INC in the same timeframe $ 0

Similar metrics to Int. Exp.:

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

CBIO - Interest Expense, Last 5 years

$ 0

Minimum

Sep 30, 2020

$ 1.07M

Maximum

Jun 30, 2025

$ 53.65K

Average

$ 0

Median

Int. Exp. Benchmark Analysis

 The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.79M with a standard deviation of $ 5.55M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.73K
min$ -15.41M
max$ 23.06M
average$ 2.79M
median$ 19.42K
std$ 5.55M